Iconovo entered into several collaboration agreements, theatest of which with the French biotech companyny Affilogic. The collaboration concerns a feasibility study with inhalable affinity proteins, so-called Nanofitins, based on Iconovo's disposable inhaler IICOone. After the study is completed, there are good opportunities to expand the collaboration, according to the company.

The goal of the project is to develop a new treatment for lung diseases.